Visits: 1696, Avg visit time (secs): 275,46 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 711 | 41,92% | |
| /gsk/efsd-gsk-recipients.html | 128 | 7,55% |
| /lilly/efsd-lilly-recipients.html | 112 | 6,60% |
| /novartis/efsd-novartis-recipients.html | 108 | 6,37% |
| /recipients.html | 64 | 3,77% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 60 | 3,54% |
| /novo-t1/efsd-novo-t1-recipients.html | 40 | 2,36% |
| /efsd-grant/efsd-clinres-recipients.html | 26 | 1,53% |
| /pfizer/efsd-pfizer-cardiorecipients.html | 26 | 1,53% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-cvd-recipients.html | 25 | 1,47% |
| /msd/efsd-msd-recipients-islet.html | 23 | 1,36% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 786 | 46,34% |
| /novo-t1/efsd-novo-t1-recipients.html | 86 | 5,07% |
| /msd/efsd-msd-recipients-islet.html | 84 | 4,95% |
| /novo-t2/efsd-novo-t2-recipients.html | 54 | 3,18% |
| /sanofi-aventis/endocannabinoid/efsd-sanofi-aventis-ecs-recipients.html | 48 | 2,83% |
| /gsk/efsd-gsk-recipients.html | 42 | 2,48% |
| /lilly/efsd-lilly-recipients.html | 36 | 2,12% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 33 | 1,95% |
| /servier/efsd-servier-recipients.html | 31 | 1,83% |
| /pfizer/efsd-pfizer-cardiorecipients.html | 30 | 1,77% |
| /novartis/efsd-novartis-recipients.html | 28 | 1,65% |